Treatment of Parkinson's disease is in large part based on the administration of levodopa. The use of this drug is limited by the development of psychiatric complications, including a disorder similar ...

A new drug is being tested to relieve Parkinson’s disease (PD) symptoms – and it’s reportedly showing promise. The drug is designed to slow or halt the progression of the disease in patients by ...

June 26 -- WEDNESDAY, June 25 (HealthDay News) -- People taking dopamine agonists to treat Parkinson's disease are at risk for impulse-control disorders such as compulsive gambling, buying and sexual ...

In biotech, the most compelling investment stories often emerge where medical need, scientific differentiation, and timing ...

For more than 200 years, Parkinson’s disease has been treated as a one‑way street, with drugs and devices that ease symptoms but do not truly repair the brain. That assumption is now under direct ...

Symptoms of Parkinson’s disease, such as tremors and stiffness, can make daily tasks difficult. A new drug has shown promise in alleviating symptoms. (Getty Images) Tavapadon, a drug being tested to ...

A new drug has shown promise in combating Parkinson’s disease while minimizing unwanted side effects. The once-daily pill, tavapadon, was found to relieve symptoms — including stiffness, coordination, ...

FILE PHOTO: Test tubes are seen in front of a displayed Abbvie logo in this illustration (Reuters) -AbbVie's drug met the main goal in a late-stage trial when tested in patients with early Parkinson's ...

Mouse models of GBA1 Parkinson’s disease that are treated with Gain Therapeutics’ clinical-stage drug appear to have better cognitive function and lower disease biomarkers than untreated animals. The ...

Antipsychotic drugs, antiemetics, and some antibiotics can cause pseudoparkinsonism. Doctors use symptoms, medical history, and neurological exams to diagnose pseudoparkinsonism. Pseudoparkinsonism ...